Molecular Farming

PoLoPo has signed a Memorandum of Understanding with CSM Ingredients to develop egg protein powder for baking applications.

© PoLoPo
Company News

PoLoPo and CSM Ingredients Partner to Develop Price-Stable Egg Protein Powder for the Baking Industry

PoLoPo, a molecular farming startup that grows proteins in potatoes, has signed a Memorandum of Understanding with the global ingredient-tech company CSM Ingredients to develop egg protein powder for baking applications. Commercial baking uses ovalbumin, the main protein in egg whites, extensively in many products, from croissants to donuts. However, constant avian flu outbreaks are disrupting egg production and the supply chain, leading to rising egg prices and instability. The collaboration aims to provide an affordable, price-stable, and more sustainable alternative to traditional egg protein. Christian Sobolta, CSM Ingredients Group Managing Director, shared, “The global market for ovalbumin powder is projected to reach $36 billion by 2032, and PoLoPo presents an opportunity to change the dynamics of this category in a way that benefits both the planet …

more

Organisations and brands:

Molecular farming startup PoLoPo announces that it will start supplying one of its flagship proteins, patatin, for F&B products to commercial clients, pending USDA's regulatory approval.

© PoLoPo
Company News

Unexpected Demand for Affordable Patatin Pushes Molecular Farming Startup PoLoPo to Prioritize Product Launch

Molecular farming startup PoLoPo announces that it will start supplying one of its flagship proteins, patatin, for F&B products to commercial clients, pending the USDA’s regulatory approval. The Israeli startup has developed a platform to grow the egg protein ovalbumin, widely used in the food industry, and patatin in large volumes in potato tubers, securing a lower cost. As explained by the startup, patatin, the native protein of potatoes, is expected to have a relatively straightforward regulatory process. Despite being derived from genetically engineered plants, it is extracted and processed into a powder that contains no genetic material, making it non-GMO. CEO and co-founder Maya Sapir-Mir comments, “We are keeping our eyes on the prize, which is bringing molecular-farmed egg protein to market, but conversations …

more

Organisations and brands:

Polopo CEO Maya Sapir Mir

Polopo CEO Maya Sapir Mir
Opinion

Op Ed: Maya Sapir-Mir, PhD, CEO and Co-Founder of PoLoPo, on Growing Animal Proteins from Potatoes

Maya Sapir-Mir is CEO and co-founder of PoLoPo, a molecular farming pioneer producing proteins directly in common crops, beginning with egg protein (ovalbumin) grown in potatoes. PoLoPo last year raised $2.3 million in pre-seed funding and recently unveiled its molecular farming platform, SuperAA, for producing key proteins ovalbumin and patatin. Maya has nearly ten years of experience in the biotech industry and agricultural R&D and holds a PhD in plant sciences from the Hebrew University of Jerusalem. She performed post-doctoral work at the Volcani Institute, Israel’s leading agricultural R&D facility, in protein identification, extraction, and characterization in plants and microorganisms. Here, she explains the importance of this emerging biotechnology; “Instead of inefficiently growing plants to feed animals crowded in factory farms, molecular farming gives us …

more

Organisations and brands:

Motif FoodWorks Burger with HEMAMI

©Motif FoodWorks
Company News

Motif FoodWorks Partners with IngredientWerks to Explore Creating Animal-Free Heme From Corn

Food tech startup Motif FoodWorks announces it is partnering with IngredientWerks, an agtech ingredients company, to develop high-value plant-based proteins for the alt-protein market. Through the research partnership, the two companies say they will explore new ways to optimize heme protein production through molecular farming.  According to Motif, the partners have begun an exploratory study aimed at recreating Motif’s HEMAMI™ ingredient using corn. HEMAMI is used to give plant-based meats the same flavor and aroma as animal-based meat, and is said to be bioidentical to the bovine heme protein found in beef. IngredientWerks will aim to produce Motif’s HEMAMI using broad-acre crops such as corn. If successful, Motif says enabling crop protein production in its ingredient strategy will lower both production costs and the carbon footprint …

more

Organisations and brands:

Bright Biotech founder Mohammad El Hajj

Co-founder and CEO Mohammad El Hajj © Bright Biotech
Cultivated, Cell-Cultured & Biotechnology

Bright Biotech Closes Oversubscribed Round for “Game-Changing” Plant Chloroplast Technology

UK-based Bright Biotech has secured $3.2 million in funding in an oversubscribed seed round. The startup’s technology harnesses valuable proteins in the chloroplasts of plants that can help cultivated meat companies achieve industrial production affordably. More expensive than diamonds Growth factors make up at least 55% of the marginal cost of cultivated meat. According to Bright Biotech, astonishingly, growth factors can cost several million dollars per gram making them more expensive by weight than diamonds. As a solution to this bottleneck, the Manchester startup says it can manufacture and supply premium growth factors at minimal cost using proteins produced by plants, through an innovative technology that harnesses chloroplasts to express large amounts of high-value proteins with large yields. It adds that its chloroplast-based expression is light-driven, …

more

Moolec Science

©Moolec Science
Stock market

$504M Moolec to Become “World’s First” Molecular Farming FoodTech Listed on Nasdaq

Moolec Science has entered a new business agreement that will see it become the first molecular farming foodtech to be listed on Nasdaq. The foodtech ingredient pioneer is aiming to become a category creator in the alternative protein landscape and has entered a definitive business combination agreement with LightJump Acquisition Corp, a special purpose acquisition company. UK-based Moolec focuses on developing real animal proteins in plants using molecular farming; a scalable, affordable, and sustainable technology which is the production of animal proteins using plants as small factories. The transaction sets Moolec’s proforma equity value at $504 million and upon closing the combined company is expected to be listed on Nasdaq under the ticker symbol “MLEC”.  Targeting the rapidly expanding alt protein sector, Moolec claims its …

more

Organisations and brands:

Cultivate Tomorrow Cell Ag Hackathon Event

©Cultivate Tomorrow
Science

Moolec Science Expands Portfolio in Mission to “Address Dependency of Animal Proteins in Every Segment of the Food Industry”

Moolec Science, a global Ag-Foodtech company based in the UK whose purpose is improving the affordability of animal-free food solutions, presents its latest two developments which join its working portfolio of meat analogs made with blends of soybean with selected porcine proteins and pea with bovine proteins.

more

Organisations and brands:

Moolec Science molecular farming

© Moolec Science
Company News

Moolec Science: Using Molecular Farming to Make Alternative Proteins

Moolec Science is working on developing meat substitutes through “molecular farming” — the use of plant cells to produce large quantities of a substance from proteins. Previously, this technology was mostly used in the pharmaceutical industry. But after Moolec’s founders saw that it had other applications, the company was born.

more

Organisations and brands: